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Chemicals Policy Gap
Toward Stronger Regulation in the United States
Chemicals policy in the United States is in need of profound change 
for both environmental health and economic reasons, according to 
a review of how the U.S. chemical industry currently is regulated 
[EHP 117:1202–1209; Wilson and Schwarzman]. The 1976 Toxic 
Substances Control Act (TSCA), which provides the chief legal 
authority for regulating industrial chemicals in the United States, is 
antiquated and ineffective, according to the authors. 
Reform of TSCA is especially urgent in view of the European 
Union’s passage in 2006 of the Registration, Evaluation, Authorisation 
and Restriction of Chemicals (REACH) legislation. REACH’s more 
stringent and transparent rules for regulating industrial chemicals 
could put the United States at risk of becoming a market for hazard-
ous chemicals that become banned in Europe. Without a parallel 
transformation in U.S. chemicals policy and a strong commitment to 
green chemistry, the United States could face growing health and envi-
ronmental problems and will have difficulty meeting the challenges of 
environmental and economic sustainability, the authors write. 
TSCA currently requires chemical producers to disclose little toxi-
cologic or other test data, creating a data gap that prevents the public 
and downstream users of chemicals from making informed purchas-
ing decisions. The U.S. Environmental Protection Agency bears the 
burden of proving that a chemical should be regulated (as opposed to 
the manufacturer proving that the chemical need not be regulated), 
and a lack of governmental tools to evaluate and mitigate chemical 
hazards has produced a safety gap. In concert with the first two gaps, 
the lack of investment in green chemistry research and development 
has produced a technology gap, with the United States at risk of fall-
ing behind the European Union and other industrialized nations in 
this area. 
The authors argue that the three gaps have produced a chemicals mar-
ket that values function, price, and performance over safety while external-
izing the costs of chemically related health and environmental damage to 
the public. These market and regulatory conditions also pose a key barrier 
to the scientific and commercial success of green chemistry in the United 
States and could hinder the U.S. chemical industry’s global competitive-
ness as green chemistry technologies accelerate under REACH.
Global chemical production is expected to double in the next 
24 years, according to the United Nations and other sources, and the 
Environmental Protection Agency has estimated the United States will 
need 217,000 new hazardous waste sites in the next 20 years. Concluding 
that “the vast potential of green chemistry remains untapped,” the authors 
call for “a chemicals policy that departs markedly from the federal policies 
of the last 30 years, of which TSCA is emblematic.” Taking advantage of 
this opportunity, they write, would propel the United States toward new 
chemistries that are safer for occupational, environmental, and public 
health—the cornerstone of a truly sustainable society. 
Valerie J. Brown, based in Oregon, has written for EHP since 1996. In 2009 she won a 
Society of Environmental Journalists’ Outstanding Explanatory Reporting award for her 
writing on epigenetics.
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The Vulnerability of the 
Older Child
A New Approach to Identifying Ages When 
Children Are Most Susceptible to Lead Effects
Watch a toddler, and you quickly see why small children are so vul-
nerable to environmental exposures: most of what they touch goes 
right into their mouths. It’s no wonder, then, that lead levels gener-
ally peak at age 2 years, which is when health officials recommend 
children be tested for elevated blood lead. But new research shows 
that 5- to 6-year-olds may be particularly vulnerable to the cognitive 
and behavioral effects of lead and should be tested as well if such 
problems are apparent [EHP 117:1309–1312; Hornung et al.]. 
Previous studies have suggested that IQ scores at ages 
5–7 years are more strongly associated with concurrent blood 
lead concentrations than with concentrations measured at age 2. 
However, children’s blood lead concentrations during infancy are 
strongly associated with concentrations at older ages—meaning, for 
instance, a highly exposed toddler still tends to be highly exposed 
at age 6. This “serial correlation” makes it difficult to determine 
whether lead has a cumulative effect or whether effects of lead differ 
according to age. 
In the current study, researchers analyzed blood lead concentra-
tion data for 462 children who participated in either the Cincinnati 
Lead Study, which enrolled children from 1979 to 1984, or the 
Rochester Longitudinal Study, which enrolled children from 1994 
to 1995. In both studies the children’s blood lead was measured 
every year from infancy to age 6. The children also took IQ tests 
around age 6. 
To study effects of lead at different ages while accounting for 
correlations in lead levels over time, the researchers estimated 
effects of the ratio of the child’s blood lead at age 2 relative to his 
or her blood lead at each subsequent age (3–6 years). As the ratio of 
age 6:age 2 blood lead increased, IQs declined even after control-
ling for average lead exposure at all ages as well as a range of other 
covariates. In addition, children who had relatively higher lead 
exposure at age 5 or 6 compared with age 2 had significantly higher 
arrest rates for criminal behavior in adulthood than other children.
The results suggest that blood lead testing and efforts to reduce 
exposure should continue as children reach school age. Moreover, 
lead testing of school-age children with cognitive or behavioral prob-
lems may help identify underlying causes of difficulties teachers or 
parents are seeing. 
Tina Adler first wrote for EHP about the Clinton–Gore environmental agenda in 1993. She is a 
member of the National Association of Science Writers and the American Society of Journalists 
and Authors.
Although blood lead concentrations tend to 
decline after toddlerhood, older children may be 
more susceptible to adverse effects of exposure.A Framework to Monitor Toxics
Measuring the Health Impact of Chemical Bans
One of the tasks mandated by the Stockholm Convention on 
Persistent Organic Pollutants is to determine if bans on toxic sub-
stances are effective in reducing contamination in people. But assess-
ing such trends in diverse global populations is difficult because 
researchers must use changes in the average levels of contaminants 
measured in groups of people at different points in time—known as 
cross-sectional trend data—to estimate how levels are changing in 
individuals over time. A team of Swiss researchers has developed a 
pharmacokinetic model framework that may help improve the use 
of cross-sectional trend data in assessing the effects of chemical bans 
[EHP 117:1280–1286; Ritter et al.].
Among the parameters required by the model are the rate of 
elimination of the contaminant from the body and the rate of decline 
of individual intake of the contaminant once a ban takes effect. 
Additional parameters include body weight and the fraction of the 
body weight that is lipid. The authors tested their formulas with sam-
ple cases involving p,p´-DDT and p,p´-DDE from selected Swedish 
and U.K. populations, and found that the outcomes matched fairly 
well with concentrations identified in earlier studies.
As with any model, however, a key to its successful application is 
good data for the variables included in the model. The authors note 
that total diet studies, which are regularly conducted in a number of 
countries, are a good source of data to estimate changes in contami-
nant intake over time, because food is typically the primary source of 
on  going exposures in postban situations. 
The model assumes that cross-sectional averages used to esti-
mate changes in contaminant levels over time are based on data 
from populations that are similar in age and other factors that 
would influence initial body burden and contaminant intake and 
elimination. The key is that changes in intakes be reasonably con-
sistent among members of the population, but they need not be 
consistent for the population over time if data are available to esti-
mate changes in dietary intake. Modeling data from populations 
that are reasonably similar with regard to these characteristics also 
means that results from the model will be population-specific and 
not necessarily applicable to other populations.
Still, the authors say the model is broadly adaptable, and the 
formulas can be modified to factor in considerations such as path-
ways other than ingestion, storage in body reservoirs other than 
fat tissue, and different elimination rates. To optimize the use of 
this model, the authors recommend that efforts to monitor toxics 
include regular data collection, including total diet data to estimate 
background levels of ongoing exposure, in young adult populations. 
Bob Weinhold, MA, has covered environmental health issues for numerous outlets since 
1996. He is a member of the Society of Environmental Journalists.
Southern Discomfort?
PON1 Variation May Help Explain Regional CVD Risk
Age-associated rates of cardiovascular disease (CVD) are higher 
in the Southern states (except Florida) than anywhere else in the 
United States, and higher among Southern blacks than Southern 
whites. Animal studies suggest that higher levels of activity of the 
enzyme paraoxonase-1 (PON1) may lower the risk of CVD, spe-
cifically atherosclerosis, but evidence linking functional variations 
in PON1 to atherosclerosis risk in humans has been ambiguous. 
New research correlates functional variation in PON1 activity 
with race, which may help explain demographic variation in CVD 
prevalence [EHP 117:1226–1231; Davis et al.].
PON1 is carried by high-density lipoprotein in the blood and 
is involved in the hydrolysis, or breakdown, of oxidized low-density 
lipoprotein, whose buildup is considered an early step in the devel-
opment of atherosclerosis. PON1 is also involved in the hydrolysis of 
the toxic oxon metabolites of certain organophosphate insecticides. 
A single-nucleotide polymorphism at position 192 on the PON1 
gene results in two functional variations of the enzyme, the Q and 
R forms. Other studies have associated the R form with a greater 
risk of atherosclerosis. The R form also hydrolyzes chlor  pyrifos 
oxon more effectively than the Q form, whereas both alloforms 
are equally effective at metabolizing diazoxon; neither hydrolyzes 
paraoxon quickly enough to offer protection. PON1 activity is also 
linked to the quantity of the enzyme in the blood, which is con-
trolled in part by polymorphisms in the gene’s promoter region and 
may vary by at least 13-fold among individuals. 
The researchers analyzed serum samples for 200 adult black and 
white men and women (50 in each sex–race group) obtained from 
blood banks in Alabama and Tennessee. The team determined 
PON1 functional genotypes—RR, QR, or QQ—by measuring 
rates of hydrolysis of paraoxon and diazoxon. They also analyzed 
arylesterase activity (another measure of PON1 activity), levels of 
cotinine (a biomarker of smoking, which can affect PON1 levels), 
and C-reactive protein (a biomarker of inflammation associated 
with greater risk of CVD).
Forty-four percent of black subjects had higher in vitro rates of 
paraoxon hydrolysis and lower rates of diazoxon hydrolysis, consis-
tent with the RR genotype that has been hypothesized to increase 
the risk of CVD. In contrast, only 7% of white subjects had activ-
ity levels consistent with the RR genotype. Black subjects also had 
higher levels of C-reactive protein, consistent with a greater risk of 
CVD. However, levels of C-reactive protein were not associated 
with PON1 activity. Cotinine levels indicated that all study par-
ticipants were nonsmokers—possibly the result of the blood banks 
having screened out smokers. 
The authors conclude their data support the idea that the func-
tional RR genotype is less protective of cardio  vascular health. They 
are working on a follow-up study of Southerners of both races and 
sexes where there is more information about participants’ health 
status and medical history. 
Kris S. Freeman has written for Encarta encyclopedia, NIH, ABCNews.com, and the National 
Park Service. Her research on the credibility of online health information appeared in the 
June 2009 IEEE Transactions on Professional Communication.
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PON1 helps break down 
pesticides in the body.